Phillipe Wanstok lands the newly created chief commercial officer position at CVRx.
CVRx names new chief commercial officer
Minnesota-based CVRx created a new chief commerical officer position and named Philippe Wanstok as its occupant. Wanstok was previously the international general manager of commercial operations with the cardiac rhythm disease management division at Medtronic (NYSE:MDT).
As CCO at CVRx, Wanstok will primarily oversee the global commercializiation of its hypertension-managing device, Barostim Neo. The device, which received CE Mark approval in the European Union earlier this month, has yet to receive FDA clearance.